HB1852

AN ACT to amend Tennessee Code Annotated, Title 33; Title 37; Title 44; Title 47; Title 49; Title 53; Title 63 and Title 68, relative to health.

Failed·3/10/26
Draft Text

Tennessee mRNA Pharmaceutical Sovereignty and Safety Act aims to prohibit the administration of mRNA vaccines in Tennessee.

The Tennessee mRNA Pharmaceutical Sovereignty and Safety Act seeks to impose a moratorium on the administration of mRNA vaccines in Tennessee, citing concerns about their safety and efficacy. The act defines "mRNA vaccine or vaccine material" and prohibits their administration by healthcare providers, with violations subject to fines and potential administrative sanctions. The act takes effect January 1, 2027.

Included in complete analysis

  • Overview
  • Core Provisions
  • Implementation
  • Impact
  • Legal Framework
  • Critical Issues

See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.

Sponsors

0
1
R
Democratic CaucusRepublican Caucus

History

Mar 10

House

Failed for lack of motion in: Population Health Subcommittee

Mar 4

House

Placed on s/c cal Population Health Subcommittee for 3/10/2026

Feb 2

House

P2C, ref. to Health Committee